AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Study says Cypher stent superior to bare-metal stents.

Medical Device Week

| September 18, 2006 | COPYRIGHT 2006 AHC Media LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Study says Cypher stent superior to bare-metal stents

A Medical Device Daily Staff Report

Cordis (Miami Lakes, Florida) reported that the Cypher sirolimus-eluting coronary stent reduced the risk of target-vessel failure (TVF) by almost half in patients who suffered acute myocardial infarction (AMI), compared to those treated with balloon angioplasty and a bare-metal stent (BMS), according to data appearing recently in the New England Journal of Medicine.

At one year post-implantation, the study found that patients given the Cypher stent were 49% less likely to experience TVF than those given a BMS. Patients in the Cypher stent arm had a TVF rate of 7.3% compared to 14.3% in the BMS arm of the study (p

The data were originally presented at the American College of Cardiology annual scientific session in March. TYPHOON (the trial to assess the use of the Cypher Stent in AMI treated with balloon angioplasty), sponsored by Cordis, is the first to study the safety and efficacy of the Cypher stent in patients who have suffered an AMI, the company said. Data were reported on 712 patients who had suffered an AMI within 12 hours before the stent placement. TYPHOON was conducted at 48 sites across Europe, Israel and Australia.

Related articles from newspapers, magazines, journals, and more
Data from new studies backs the promise of Cypher stent.
Newspaper article from: Medical Device Daily September 3, 2003 700+ words
...studies backs the promise of Cypher stent By HOLLAND JOHNSON Medical Device Daily Senior Staff Writer At...maintained at 12 months with a Cypher Stent MACE rate of 8.6% compared...clinical trials involving the Cypher stent, said Schofer. The patients...
Cordis webcast focuses on recent Cypher stent issues.
Newspaper article from: Medical Device Daily December 5, 2003 700+ words
...webcast focuses on recent Cypher stent issues By HOLLAND JOHNSON Medical Device Daily Senior Staff Writer In...hypersensitivity associated with the Cypher stent, and surgeons discussed...thrombosis between a Cypher stent and that expected for...
FDA: reports of adverse events, deaths related to Cypher stent.
Newspaper article from: Medical Device Daily October 30, 2003 700+ words
...events, deaths related to Cypher stent By DON LONG Medical Device Daily Managing Editor The FDA...associated with use of the Cypher stent. The term sub-acute was...days, post procedure. The Cypher stent is coated with a thin polymer...
Meta-analysis of 7 studies gives edge to Cypher stent.
Newspaper article from: Medical Device Daily October 21, 2005 700+ words
...7 studies gives edge to Cypher stent By AARON LORENZO Medical Device Daily Washington Editor A head...rates. Specifically, the Cypher stent reduced the need for retreatment...New Jersey). ?The Cypher stent?s strong clinical performance...
Study says Cypher stent superior to bare-metal stents.
Newspaper article from: Medical Device Daily September 18, 2006 700+ words
Study says Cypher stent superior to bare-metal stents A Medical Device Daily Staff Report Cordis...that patients given the Cypher stent were 49% less likely...BMS. Patients in the Cypher stent arm had a TVF rate of...
Panel backs Cypher stent, but investors question timing.
Newspaper article from: Medical Device Daily October 24, 2002 700+ words
Panel backs Cypher stent, but investors question timing By DON LONG Medical Device Daily Managing Editor As expected, the Cypher drug-eluting stent from the Cordis (Miami Lakes, Florida) unit of Johnson &...
New Data on the Clinical Performance of the CYPHER Stent In Long Lesions,...
Press release article from: PR Newswire September 24, 2004 700+ words
...abstracts and posters examine the CYPHER Stent, which remains the most studied drug...stent available today. Among the key CYPHER Stent presentations at the international medical...will provide comparative data on the CYPHER Stent and Taxus Stent; an integrated analysis...
Cypher stent featured in more than 25 studies at the AHA meeting.
Newspaper article from: Life Science Weekly December 7, 2004 700+ words
...Sessions in New Orleans, Louisiana. The Cypher Stent remains the most studied drug-eluting...available today. Among the more than 25 key Cypher Stent presentations at the international medical...patients; and studies that evaluate the Cypher Stent's performance in complex cases, ...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA